Bioinformatic analysis revealed increased or decreased LYPD6 and LYPD6B expression in different neuropsychiatric disorders: autism, Parkinson’s and Huntington’s diseases, epilepsy, and others. This evidence concerns the gene LYPD6B and Parkinson disease.